Comparison of Myrtus Communis L. and Descurainia Sophia L. versus salicylic acid in the treatment of wart
Phase 2
- Conditions
- Wart.Viral warts
- Registration Number
- IRCT2012092710947N1
- Lead Sponsor
- Vice-Chancellor for Research (Tehran University of Medical Sciences)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1) Patients between 6 to 45 years old 2) Patients who live in Yazd 3) Total number of wart <=20 and their largest diameter <= 1 cm. Exclusion criteria: 1) Patients less than 6 years old and more than 45 years old 2) Pregnancy 3) DM, nephropathy, cardiovascular diseases 4) Patients who use insulin or Sulfonylureas drugs 5) Total number of wart >20 6) Warts on face 7) anogenital warts 8) Wound or active dermatologic diseases on warts 9) Receiving any treatment during prior month 10) Patients disaffiliation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of warts. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Observation.;The size of warts. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: In millimeter by ruler.;The period of time that warts recovered after beginning of treatment. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Day.;The relapse rate. Timepoint: Days 0, 20, 40 and 3 months after beginning of treatment. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method